Global Carcinoembryonic Antigen (CEA) Market Size By Application, By Gender, By End-users, By Geographic Scope And Forecast

Carcinoembryonic Antigen (CEA) Market Size And Forecast

Carcinoembryonic Antigen (CEA) Market size was valued at USD 2.34 Billion in 2024 and is projected to reach USD 3.77 Billion by 2031, growing at a CAGR of 6.10% from 2024 to 2031.

The rising prevalence of cancer and growing awareness are a few of the critical Carcinoembryonic Antigen (CEA) Market drivers and trends fueling the growth of the market. The Global Carcinoembryonic Antigen (CEA) Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Carcinoembryonic Antigen (CEA) Market Definition

Carcinoembryonic antigen (CEA) is a protein that is usually present at very low levels in the blood of adults. However, the CEA level in the blood may be increased in certain types of cancer and non-cancerous (benign) conditions. A Carcinoembryonic antigen (CEA) test is generally used for colorectal cancer. The carcinoembryonic Antigen test helps the doctor find out if cancer has grown and whether the treatment is working. The test can often help to check whether the cancer is spreading to other parts of the body.

Global Carcinoembryonic Antigen (CEA) Market Overview

The increasing incidence rate of cancer disease is an important driver for the Global Carcinoembryonic Antigen (CEA) Market. The rapidly increasing geriatric population are prone to chronic diseases including cancer. Also, increasing consumption of alcohol-based drinks, fast food and sedentary living are factors that have contributed to cancer prevalence. The youth are inclined towards exploring less explored destinations. Other important drivers are favourable government initiatives and growing cancer awareness among the population and high demand for minimally invasive diagnostic procedures.

Continuous improvement and development of novel immunological techniques are expected to provide new profitable opportunities leading to the growth of the Carcinoembryonic Antigen (CEA) Market. Other opportunities lie in the development of novel biomarkers and increasing per-capita healthcare expenditure. Thus, there are ample growth opportunities for the market. However, there are some restraints like the lack of public awareness regarding the application of CEA tests and the risk of infections by CEA testing.

Global Carcinoembryonic Antigen (CEA) Market Segmentation Analysis

The Global Carcinoembryonic Antigen (CEA) Market is segmented based on Application, Gender, End-users, and Geography.

Carcinoembryonic Antigen (CEA) Market, By Application

• Gastrointestinal Cancer
• Breast Cancer
• Lung Cancer
• Others

Based on Application, The market is segmented into Gastrointestinal Cancer, Breast Cancer, Lung Cancer, and Others. Gastrointestinal cancer leads the market segment by application followed by breast and lung cancer.

Carcinoembryonic Antigen (CEA) Market, By Gender

• Male
• Female

Based on Gender, The market is segmented into Male and Female. Male has a higher share in CEA market when compared to female. This can be explained by the fact that cancer affects men more often than women due to certain habits serving as risk factors, such as smoking and drinking.

Carcinoembryonic Antigen (CEA) Market, By End-Users

• Hospitals
• Diagnostic Centres
• Research and academic institutes
• Family
• Others

Based on End-Users, The market is segmented into Hospitals, Diagnostic Centres, Research and Academic Institutes, Family, and Others.

Carcinoembryonic Antigen (CEA) Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

On the basis of Geography, The Global Carcinoembryonic Antigen (CEA) Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America leads the global Carcinoembryonic Antigen (CEA) market by geography due to factors such as the high incidence rates of cancers, presence of advanced healthcare infrastructure, higher healthcare expenditure, and higher public awareness levels. The Asia Pacific is expected to show good growth due to rapidly improving healthcare infrastructure, economic development, and increasing awareness among patients.

Key Players

The “Global Carcinoembryonic Antigen (CEA) Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Quest Diagnostics, Abbott Diagnostics, Roche Diagnostics, GenWay Biotech Inc., Correlogic Systems, Inc., Creative Diagnostics, Omega Diagnostics Group PLC, RayBiotech Inc., and Boster Biological Technology. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Report Scope

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.